GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] the compounding gap was a symptom, not a solution — 30 comments in the full submission. View in context.
662
c/compounding·submitted 13 days ago by u/hassan_chowdhury

[Discussion] the compounding gap was a symptom, not a solution

Discussionbranch of 13 comments

Genuinely asking, not being difficult. Everyone in c/glp1canada repeats that 503B is important. I believe it, but I have never seen anyone show why, and when I search I get 2 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because it…

Read the full submission and all 30 comments →

This branch

13 comments, started 12 days ago
u/emil_okwuosa51 points·12 days ago

state board rules differ, say which state

replysharereportpermalink
u/hassan_chowdhuryOP20 points·11 days ago

Are we talking 503A or 503B?

replysharereportpermalink
u/elise_ramos11 points·11 days ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
load more comments (1) →
u/usp_appendixMOD26 points·11 days ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/ahmed_fonseca20 points·11 days ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/joaquin_trevino14 points·11 days ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
[deleted]7 points·11 days ago

[deleted]

replysharereportpermalink
u/marit_mwangi11 points·11 days ago

The confident tone is doing a lot of work that the evidence is not.

Yes, exactly this, and it is the bit that took me 26 weeks to accept.

replysharereportpermalink
u/stubborn_batchlist_pls7 points·11 days ago

Not to be pedantic but 503A and state board are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/emeka_chowdhury30 points·11 days ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/enzo_ferrari25 points·11 days ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/hassan_chowdhuryOP11 points·10 days ago

the shortage list is temporary, it ends and compounding becomes illegal again

Disagree on that part. 97.4% and 96.2% on the same vial is normal.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.